Provisional patent for weight loss compound
Friday, 27 February, 2009
Diagnostics company HealthLinx and industry group Dairy Australia have filed a provisional patent for a dairy-derived bioactive compound that has shown weight loss potential in rats.
The compound, LAP001, was identified from fractionated proteins in dairy products. It was found to reduce the production and storage of fat in rat cells.
The activity was confirmed by an independent research institute, HealthLinx said in a statement. Further analysis is being undertaken.
HealthLinx said there was the potential to develop the compound as a nutraceutical.
Placebo pain relief works differently across the human body
Researchers have used placebo pain relief to uncover a map-like system in the brainstem that...
COVID infection ages blood vessels, particularly in women
Blood vessels gradually become stiffer with age, but a new study by international researchers...
Lead exposure linked to memory problems, even decades later
Historic lead levels from the era of leaded petrol may be contributing to cognitive issues 50...
